Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study.

Marchesi, F

Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study. [electronic resource] - Transplant infectious disease : an official journal of the Transplantation Society Dec 2014 - 1032-8 p. digital

Publication Type: Journal Article

1399-3062

10.1111/tid.12309 doi


Adult
Aged
Antineoplastic Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Boronic Acids--administration & dosage
Bortezomib
Cytomegalovirus Infections--pathology
Dexamethasone--administration & dosage
Doxorubicin--administration & dosage
Female
Humans
Immunologic Factors--administration & dosage
Male
Middle Aged
Multiple Myeloma--therapy
Pyrazines--administration & dosage
Retrospective Studies
Risk Factors
Stem Cell Transplantation
Vincristine--administration & dosage